Genprex TUSC2 Research to Be Presented at GSA 2026
Genprex said research on TUSC2 gene therapy and cellular resilience will be presented at the GSA 2026 Annual Scientific Meeting.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Genprex said research on TUSC2 gene therapy and cellular resilience will be presented at the GSA 2026 Annual Scientific Meeting.